Annual SG&A
$18.82 M
+$5.94 M+46.16%
31 December 2023
Summary:
Acumen Pharmaceuticals annual selling, general & administrative expenses is currently $18.82 million, with the most recent change of +$5.94 million (+46.16%) on 31 December 2023. During the last 3 years, it has risen by +$17.47 million (+1293.04%). ABOS annual SG&A is now at all-time high.ABOS Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$5.02 M
+$170.00 K+3.51%
30 September 2024
Summary:
Acumen Pharmaceuticals quarterly selling, general & administrative expenses is currently $5.02 million, with the most recent change of +$170.00 thousand (+3.51%) on 30 September 2024. Over the past year, it has increased by +$158.00 thousand (+3.25%). ABOS quarterly SG&A is now -5.77% below its all-time high of $5.33 million, reached on 31 March 2024.ABOS Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$1.01 B
-$81.67 M-8.83%
30 September 2024
Summary:
Acumen Pharmaceuticals TTM selling, general & administrative expenses is currently -$1.01 billion, with the most recent change of -$81.67 million (-8.83%) on 30 September 2024. Over the past year, it has dropped by -$1.02 billion (-5976.88%). ABOS TTM SG&A is now -3633.17% below its all-time high of $20.38 million, reached on 30 September 2024.ABOS TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABOS Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +46.2% | +3.3% | -5976.9% |
| 3 y3 years | +1293.0% | +135.0% | -10000.0% |
| 5 y5 years | - | - | - |
ABOS Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +1293.0% | -5.8% | +135.0% | -219.1% | at low |
| 5 y | 5 years | at high | +1932.4% | -5.8% | +2160.4% | -3633.2% | at low |
| alltime | all time | at high | +1932.4% | -5.8% | +2160.4% | -3633.2% | at low |
Acumen Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $5.02 M(+3.5%) | $20.38 M(+0.8%) |
| June 2024 | - | $4.85 M(-9.0%) | $20.23 M(+2.6%) |
| Mar 2024 | - | $5.33 M(+2.5%) | $19.72 M(+4.8%) |
| Dec 2023 | $18.82 M(+46.2%) | $5.19 M(+6.9%) | $18.82 M(+9.9%) |
| Sept 2023 | - | $4.86 M(+11.9%) | $17.13 M(+11.7%) |
| June 2023 | - | $4.34 M(-1.7%) | $15.33 M(+8.9%) |
| Mar 2023 | - | $4.42 M(+26.3%) | $14.08 M(+9.3%) |
| Dec 2022 | $12.88 M | $3.50 M(+14.4%) | $12.88 M(+6.3%) |
| Sept 2022 | - | $3.06 M(-0.9%) | $12.12 M(+8.3%) |
| June 2022 | - | $3.09 M(-4.1%) | $11.19 M(+20.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $3.22 M(+17.5%) | $9.29 M(+27.6%) |
| Dec 2021 | $7.28 M(+438.8%) | $2.74 M(+28.4%) | $7.28 M(+40.5%) |
| Sept 2021 | - | $2.13 M(+79.9%) | $5.18 M(+58.3%) |
| June 2021 | - | $1.19 M(-2.3%) | $3.27 M(+39.6%) |
| Mar 2021 | - | $1.22 M(+88.7%) | $2.34 M(+73.5%) |
| Dec 2020 | $1.35 M(+45.9%) | - | - |
| Dec 2020 | - | $644.00 K(+185.0%) | $1.35 M(+91.1%) |
| Sept 2020 | - | $226.00 K(-12.7%) | $707.00 K(+47.0%) |
| June 2020 | - | $259.00 K(+16.7%) | $481.00 K(+116.7%) |
| Mar 2020 | - | $222.00 K | $222.00 K |
| Dec 2019 | $926.00 K | - | - |
FAQ
- What is Acumen Pharmaceuticals annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Acumen Pharmaceuticals?
- What is Acumen Pharmaceuticals annual SG&A year-on-year change?
- What is Acumen Pharmaceuticals quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Acumen Pharmaceuticals?
- What is Acumen Pharmaceuticals quarterly SG&A year-on-year change?
- What is Acumen Pharmaceuticals TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Acumen Pharmaceuticals?
- What is Acumen Pharmaceuticals TTM SG&A year-on-year change?
What is Acumen Pharmaceuticals annual selling, general & administrative expenses?
The current annual SG&A of ABOS is $18.82 M
What is the all time high annual SG&A for Acumen Pharmaceuticals?
Acumen Pharmaceuticals all-time high annual selling, general & administrative expenses is $18.82 M
What is Acumen Pharmaceuticals annual SG&A year-on-year change?
Over the past year, ABOS annual selling, general & administrative expenses has changed by +$5.94 M (+46.16%)
What is Acumen Pharmaceuticals quarterly selling, general & administrative expenses?
The current quarterly SG&A of ABOS is $5.02 M
What is the all time high quarterly SG&A for Acumen Pharmaceuticals?
Acumen Pharmaceuticals all-time high quarterly selling, general & administrative expenses is $5.33 M
What is Acumen Pharmaceuticals quarterly SG&A year-on-year change?
Over the past year, ABOS quarterly selling, general & administrative expenses has changed by +$158.00 K (+3.25%)
What is Acumen Pharmaceuticals TTM selling, general & administrative expenses?
The current TTM SG&A of ABOS is -$1.01 B
What is the all time high TTM SG&A for Acumen Pharmaceuticals?
Acumen Pharmaceuticals all-time high TTM selling, general & administrative expenses is $20.38 M
What is Acumen Pharmaceuticals TTM SG&A year-on-year change?
Over the past year, ABOS TTM selling, general & administrative expenses has changed by -$1.02 B (-5976.88%)